The 2017 McDonald criteria further simplify the use of MRI compared with the 2010 criteria.
Sponsoring Organization: International Panel on Diagnosis of Multiple SclerosisTarget Population: Patients with a clinically isolated syndrome suggestive of multiple sclerosis (MS)
Background and Objective
An international group of experts has revised the 2010 McDonald MS criteria.
Key Points
The 2017 criteria continue to permit dissemination in space (DIS) with as few as two lesions in two locations (periventricular, juxtacortical, infratentorial, spinal cord). Changes to DIS include:
The criteria continue to permit dissemination in time (DIT) with a gadolinium-enhancing (Gd+) lesion at onset or …
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)